Vaxart, Inc. (VXRT) Total liabilities 2016–2025
Vaxart, Inc. (VXRT) total liabilities at each fiscal year-end, per SEC filings.
$98.3MFY2025 · since FY2016: $21.4M → $98.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98.3M | -8.5% |
| FY2024 | $107.5M | +215.8% |
| FY2023 | $34.0M | -21.3% |
| FY2022 | $43.3M | +28.6% |
| FY2021 | $33.6M | +15.3% |
| FY2020 | $29.2M | +21.2% |
| FY2019 | $24.1M | +0.4% |
| FY2018 | $24.0M | -44.5% |
| FY2017 | $43.2M | +102.1% |
| FY2016 | $21.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More VXRT financial trends
VXRT RevenueVXRT Net incomeVXRT Net marginVXRT Gross profitVXRT Gross marginVXRT Operating incomeVXRT Operating marginVXRT Operating cash flowVXRT Free cash flowVXRT Capital expendituresVXRT Return on equityVXRT Stock buybacksVXRT Dividends paidVXRT Total assetsVXRT Shareholders’ equityVXRT overview →